Roche to purchase InterMune in $8.3 billion deal By: CNBC.com News August 24, 2014 at 12:27 PM EDT Biotech firm Roche announced plans Sunday to buy InterMune for $8.3 billion on a fully diluted basis in an all-cash transaction. Read More >> Related Stocks: Rogers Corp